Oncolytics Biotech Inc. (ONCY)

[wizeman]

One would think any improvement into current chemo treatments would catch the eye of FDA doctors and fast track them into service. Granted Oncolytic's does not want law suits for unforseen liabilities later on down the road so FDA approval is primarily based on percentages (%) of tumor shrinkage and side affects.

Oncolytics has already done well in proving the combination of Reolysin and several drugs used in unison during Chemo work more diligent as a team than without Reolysin. There are so many companies competing for drug entry into the fighting cancer space regarding FDA approval, it's difficult for any to simply be called "THE" best method.


During the last PR 40 million thought for one small moment this one could be the next to get FDA approval waiting anxiously for some follow up PR in relation to Orphan Drug Designation. When that does not take place in the following (3) days after such announcements those stocks always recede. I truly believe Oncolytics has demonstrated their drug Reolysin has a place in today's cancer treatment market. My average share price is $1.23 for tens of thousands of shares which I have no doubt will double very soon. My biggest reason for owning shares of ONCY is this. They have a interim drug that will serve it's purpose for the next several years as other Big Pharma search for a total cure. That IMO is far off and from fruition so owning ONCY is the next best thing. If it adds 6 - 12 months or even more as time will tell for loved one to have a better quality of life during such challenging times I think 40 million others will buy into them as well. HOLDING for the first official FDA approval of many for ONCOLYTICS!